|
Originally published In Press as doi:10.1074/jbc.M008950200 on April 11, 2001
J. Biol. Chem., Vol. 276, Issue 25, 22317-22322, June 22, 2001
EWS/FLI Alters 5'-Splice Site Selection*
Lori L.
Knoop and
Suzanne J.
Baker §¶
From the § Department of Developmental Neurobiology, St.
Jude Children's Research Hospital, Memphis, Tennessee 38105 and the
Department of Pathology, University of Tennessee,
Memphis, Tennessee 38163
The chimeric gene EWS/FLI is present
in at least 85% of Ewing's sarcomas as a result of chromosomal
translocations. The resulting fusion protein contains the N terminus of
the RNA-binding protein EWS and the ETS DNA-binding domain of the
transcription factor FLI-1. Although EWS/FLI binds DNA and activates
transcription, both EWS and EWS/FLI also interact with SF1 and U1C,
essential components of the splicing machinery. Therefore, we tested
the ability of EWS and EWS/FLI to alter 5'-splice site selection using an E1A gene in vivo splicing assay. We
found that EWS/FLI, but not EWS, interfered with heterogeneous nuclear
ribonucleoprotein A1-dependent splice site selection of
E1A. Mutational analysis of EWS/FLI revealed that the
ability to affect pre-mRNA splicing coincided with transforming
activity. Therefore, EWS/FLI has the ability to influence splicing as
well as transcription.
*
This work was supported in part by National Institutes of
Health Grant PO1-CA-71907 and Cancer Center Support CORE Grant P30 CA21765 and by the American Lebanese Syrian Associated Charities.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Developmental Neurobiology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105. Tel.: 901-495-2254; Fax: 901-495-2270; E-mail: Suzanne.baker@stjude.org.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Goulet, S. Boisvenue, S. Mokas, R. Mazroui, and J. Cote
TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules
Hum. Mol. Genet.,
October 1, 2008;
17(19):
3055 - 3074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sanchez, D. Bittencourt, K. Laud, J. Barbier, O. Delattre, D. Auboeuf, and M. Dutertre
Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer
PNAS,
April 22, 2008;
105(16):
6004 - 6009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Potikyan, R. O.V. Savene, J. M. Gaulden, K. A. France, Z. Zhou, E. S. Kleinerman, S. L. Lessnick, and C. T. Denny
EWS/FLI1 Regulates Tumor Angiogenesis in Ewing's Sarcoma via Suppression of Thrombospondins
Cancer Res.,
July 15, 2007;
67(14):
6675 - 6684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Neduva and R. B. Russell
Proline-Rich Regions in Transcriptional Complexes: Heading in Many Directions
Sci. Signal.,
January 16, 2007;
2007(369):
pe1 - pe1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guillouf, I. Gallais, and F. Moreau-Gachelin
Spi-1/PU.1 Oncoprotein Affects Splicing Decisions in a Promoter Binding-dependent Manner
J. Biol. Chem.,
July 14, 2006;
281(28):
19145 - 19155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Toretsky, V. Erkizan, A. Levenson, O. D. Abaan, J. D. Parvin, T. P. Cripe, A. M. Rice, S. B. Lee, and A. Uren
Oncoprotein EWS-FLI1 Activity Is Enhanced by RNA Helicase A
Cancer Res.,
June 1, 2006;
66(11):
5574 - 5581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zou, H. Ichikawa, M. L. Blackburn, H.-M. Hu, A. Zielinska-Kwiatkowska, Q. Mei, G. J. Roth, H. A. Chansky, and L. Yang
The Oncogenic TLS-ERG Fusion Protein Exerts Different Effects in Hematopoietic Cells and Fibroblasts
Mol. Cell. Biol.,
July 15, 2005;
25(14):
6235 - 6246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Alex and K. A. W. Lee
RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains
Nucleic Acids Res.,
March 2, 2005;
33(4):
1323 - 1331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsunobu, K. Tanaka, Y. Matsumoto, F. Nakatani, R. Sakimura, M. Hanada, X. Li, Y. Oda, I. Naruse, H. Hoshino, et al.
The Prognostic and Therapeutic Relevance of p27kip1 in Ewing's Family Tumors
Clin. Cancer Res.,
February 1, 2004;
10(3):
1003 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Chang and V. B. Shidham
Molecular Genetics of Pediatric Soft Tissue Tumors: Clinical Application
J. Mol. Diagn.,
August 1, 2003;
5(3):
143 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Torchia, S. Jaishankar, and S. J. Baker
Ewing Tumor Fusion Proteins Block the Differentiation of Pluripotent Marrow Stromal Cells
Cancer Res.,
July 1, 2003;
63(13):
3464 - 3468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sjogren, J. M. Meis-Kindblom, C. Orndal, P. Bergh, K. Ptaszynski, P. Aman, L.-G. Kindblom, and G. Stenman
Studies on the Molecular Pathogenesis of Extraskeletal Myxoid Chondrosarcoma--Cytogenetic, Molecular Genetic, and cDNA Microarray Analyses
Am. J. Pathol.,
March 1, 2003;
162(3):
781 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Starck, N. Cohet, C. Gonnet, S. Sarrazin, Z. Doubeikovskaia, A. Doubeikovski, A. Verger, M. Duterque-Coquillaud, and F. Morle
Functional Cross-Antagonism between Transcription Factors FLI-1 and EKLF
Mol. Cell. Biol.,
February 15, 2003;
23(4):
1390 - 1402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S A Burchill
Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities
J. Clin. Pathol.,
February 1, 2003;
56(2):
96 - 102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Martini, R. La Starza, H. Janssen, C. Bilhou-Nabera, A. Corveleyn, R. Somers, A. Aventin, R. Foa, A. Hagemeijer, C. Mecucci, et al.
Recurrent Rearrangement of the Ewing's Sarcoma Gene, EWSR1, or Its Homologue, TAF15, with the Transcription Factor CIZ/NMP4 in Acute Leukemia
Cancer Res.,
October 1, 2002;
62(19):
5408 - 5412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Spahn, R. Petermann, C. Siligan, J. A. Schmid, D. N. T. Aryee, and H. Kovar
Interaction of the EWS NH2 Terminus with BARD1 Links the Ewing's Sarcoma Gene to a Common Tumor Suppressor Pathway
Cancer Res.,
August 15, 2002;
62(16):
4583 - 4587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ohkura, H. Yaguchi, T. Tsukada, and K. Yamaguchi
The EWS/NOR1 Fusion Gene Product Gains a Novel Activity Affecting Pre-mRNA Splicing
J. Biol. Chem.,
January 4, 2002;
277(1):
535 - 543.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Welford, S. P. Hebert, B. Deneen, A. Arvand, and C. T. Denny
DNA Binding Domain-independent Pathways Are Involved in EWS/FLI1-mediated Oncogenesis
J. Biol. Chem.,
November 2, 2001;
276(45):
41977 - 41984.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|